Barclays Maintains Overweight on Fabrinet, Raises Price Target to $739

Benzinga Newsdesk www.benzinga.com Positive 87.1%

Neg 0% Neu 0% Pos 87.1%

Barclays analyst Tim Long maintains Fabrinet (NYSE:FN) with a Overweight and raises the price target from $702 to $739.

Comments

No comments yet. Be the first!